| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/02/2008 | EP1937238A1 Novel nitrocatechol derivatives having selectin ligand activity |
| 07/02/2008 | EP1937224A2 Skincare products |
| 07/02/2008 | EP1533313B1 Novel flavone c-glycoside derivatives and composition containing the derivatives |
| 07/02/2008 | EP1501808B1 Tachykinin receptor antagonists |
| 07/02/2008 | EP1496838A4 Substituted amides |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1427436B1 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 07/02/2008 | EP1251818B1 Galenic formulation |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | EP1094781B1 Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
| 07/02/2008 | CN101212965A Topical compositions comprising nanoparticles of an isoflavone |
| 07/02/2008 | CN101212952A Agent for external application to the skin |
| 07/02/2008 | CN101210244A Neutrokine-alpha and Neutrokine-alpha splice variants |
| 07/02/2008 | CN101209338A Chinese medicine for treating cutaneous hemangioma |
| 07/02/2008 | CN101209321A Medicament for treating burn and scald |
| 07/02/2008 | CN101209318A Externally-applied Chinese medicine preparation for treating hormone dependence facial dermatitis and skin pruritus |
| 07/02/2008 | CN101209308A Method for producing medical ointment for treating skin disease |
| 07/02/2008 | CN101209280A Natural high-efficiency nontoxic anti-inflammation itch-relieving liquid |
| 07/02/2008 | CN101209269A Application of oligose in soft extract |
| 07/02/2008 | CN101209267A Use of nocardia rubracell wall skeleton in preparing medicament for treating skin damage and pyogenic infection |
| 07/02/2008 | CN101209257A Medical use of baicalin and scutellarein derivatives |
| 07/02/2008 | CN101209242A Recombination human epidermal growth factor spray and preparation method thereof |
| 07/02/2008 | CN101209232A Composition for external use |
| 07/02/2008 | CN100398544C Aqueous triptolide alcohol derivative with high immunesuppressive activity and its application |
| 07/02/2008 | CN100398541C Pyrimidinone derivatives and 3-keto ester |
| 07/02/2008 | CN100398535C Piperidine derivatives and their use as modulators of chemokine receptor activity especially CCR5 |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 07/02/2008 | CN100398147C Chinese medicine preparation for preventing and controlling baldness and its preparing method |
| 07/02/2008 | CN100398125C Chinese medicine and Western medicine combining hair restorer tincture and its preparing method |
| 07/02/2008 | CN100398118C Externally used non-toxic bacteriostatic bactericidal traditional medicine preparation and its preparing technics |
| 07/02/2008 | CN100398114C Composition of stachyose and bee product |
| 07/02/2008 | CN100398111C Powder placed inside shoes for treating foot odor and beriberi |
| 07/02/2008 | CN100398089C Solar radiation proof composition with natural component for skin |
| 07/02/2008 | CN100398012C Health-care food for anti oxidation and improving sleep |
| 07/01/2008 | US7393937 N-acetylglucosamine derivatives and use thereof |
| 07/01/2008 | US7393932 Endothelial cell expression patterns |
| 07/01/2008 | US7393859 Amide substituted imidazoquinolines |
| 07/01/2008 | US7393857 Use of 5-HT3 receptor antagonists for treating musculoskeletal diseases |
| 06/26/2008 | WO2008076949A2 Quinazoline derivatives and methods of treatment |
| 06/26/2008 | WO2008076048A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | WO2008076003A1 Composition of individual proteolytic enzymes |
| 06/26/2008 | WO2008075735A1 Prophylactic or therapeutic agent for alopecia |
| 06/26/2008 | WO2008075665A1 Transdermally absorbable preparation and adhesive sheet for application to the skin |
| 06/26/2008 | WO2008075649A1 Food or drink, quasi drug and medicinal composition for promoting hair growth and method of promoting hair growth |
| 06/26/2008 | WO2008075466A1 Food and drink, quasi drug and pharmaceutical composition for promoting hair growth, and method for promoting hair growth |
| 06/26/2008 | WO2008075333A2 Edible compositions for preventing hair loss |
| 06/26/2008 | WO2008074849A1 Method of using fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy |
| 06/26/2008 | WO2008074848A1 Method of using fluocinolone acetonide, tretinoin and hydroquinone cream in melasma maintenance therapy |
| 06/26/2008 | WO2008074253A1 Pyridazinoindole derivatives, their preparation and therapy use |
| 06/26/2008 | WO2008074128A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
| 06/26/2008 | WO2008056391A3 Composition for a pharmaceutical treatment based on triethyl citrate and adapalene |
| 06/26/2008 | US20080154030 combining niacin or niacinamide in the aqueous fluid with the cyclodextrin derivative; solubilizers |
| 06/26/2008 | US20080153916 Use of Adamantyl Methoxydiphenyl Propenoic Acid For the Treatment of Acne |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153898 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 06/26/2008 | US20080153882 Pharmaceutical Composition Comprising Ppar Regulator |
| 06/26/2008 | US20080153844 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents |
| 06/26/2008 | US20080153835 Therapeutic agents useful for treating pain |
| 06/26/2008 | US20080153796 Promotion of wound contraction |
| 06/26/2008 | US20080153795 Medicaments and methods for wound healing |
| 06/26/2008 | US20080153794 Medicaments and methods for wound healing |
| 06/26/2008 | US20080153786 Controlled release of drugs into/through the skin |
| 06/26/2008 | US20080153782 Phosphatidylcholine, phosphatidylinositol, phosphatidylethanolamine, phosphatidylserine and shingomyeline esterified by docosahexaensic acid or eicosapentaenoic acid |
| 06/26/2008 | US20080153781 Applying 4-(2,4-bistrimethylsilyphenylcarboxamide) benzoic acid; warts, eczema, dandruff |
| 06/26/2008 | US20080153757 Contains ascorbic acid, phenylalanine or tyrosine, ethyl lactate and a non-toxic zinc salt (zinc sulfate) |
| 06/26/2008 | US20080153743 Methods relating to the treatment of fibrosis |
| 06/26/2008 | US20080153741 mixture of small molecular weight nucleoprotein, deoxyoligonucleotide, DNA or RNA enzymatic or hydrolytic degradation product; obtained from fishes, yeast; easy transdermal absorption, improve hydrophilic, sebum level balance, preventing wrinkles; aging resistance |
| 06/26/2008 | US20080152697 Controlled release of an antimicrobial complex containing silver ion, zirconium, titanium or hafnium, lithium, sodium or potassium, phosphate and hydrogen that maintains its antiseptic effectiveness |
| 06/26/2008 | US20080152651 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 06/26/2008 | US20080152639 Using enzyme mixtures to control concentration of small leucine rich proteoglycans (SLRPs) and glycosaminoglycans in tissues and treat and prevent skin disorders |
| 06/26/2008 | US20080152629 Progenitor cell culture for use in partial and/or full restoration of hematopoietic function in patients who have undergone ablative therapy |
| 06/26/2008 | DE102006062120A1 Pharmazeutische Zusammensetzung zur Aknebehandlung A pharmaceutical composition for the treatment of acne |
| 06/26/2008 | DE102006062119A1 Arzneimittel zur Behandlung von Hauterkrankungen Drugs for the treatment of skin diseases |
| 06/26/2008 | DE102006061487A1 Producing an extract from aloe leaf, useful e.g. for stimulating immune system, preventing skin irritation, comprises chopping aloe leaf, mashing the aloe-leaf with buffer solution and pressing and filtering the macerate |
| 06/26/2008 | DE102006061186A1 Use of a compound containing aluminum and chlorine is used to prepare a pharmaceutical or cosmetic composition for treating skin disorders associated with inflammation, irritation or swelling |
| 06/26/2008 | DE102006060439A1 Cosmetic or dermatological composition for treating e.g. cellulite contains hyperemisating active ingredients and active ingredients for reducing the degranulation of mast cells and/or for releasing histamine |
| 06/26/2008 | CA2673841A1 Prophylactic or therapeutic agent for alopecia |
| 06/26/2008 | CA2673421A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
| 06/26/2008 | CA2673277A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 06/26/2008 | CA2672663A1 Compositions and methods of inducing hair growth utilizing cotinus coggygria |
| 06/26/2008 | CA2671530A1 Use of fluocinolone acetonide,tretinoin and hydroquinone cream in melasma maintenance therapy |
| 06/26/2008 | CA2671528A1 Use of fluocinolone acetonide,tretinion and hydroquinone cream in melasma maintenance therapy |
| 06/25/2008 | EP1935901A1 Analysis and separation of platelet-derived growth factor proteins |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule |
| 06/25/2008 | EP1934223A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 06/25/2008 | EP1933853A1 Tissue disruption treatment and composition for use thereof |
| 06/25/2008 | EP1933840A2 Use of delmopinol in the treatment of acne |
| 06/25/2008 | EP1933828A2 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion |
| 06/25/2008 | EP1933827A2 Composition comprising at least one naphthoic acid derivative and at least one compound of polyurethane polymer type or derivatives thereof, preparation processes therefor and uses thereof |
| 06/25/2008 | EP1933824A2 Hydrazone agents to treat cutaneous lesions |
| 06/25/2008 | EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/25/2008 | EP1450771B1 Pharmaceutical preparations useful for treating lesions of the skin and the mucous membranes and methods and kits using same |
| 06/25/2008 | EP1418931B1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP0942915B1 Pharmaceutical formulations |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208089A 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 Aminothiazole derivatives as human stearoyl desaturase inhibitor -CoA |
| 06/25/2008 | CN101204570A Plaster for anesthesia and preparation method thereof |